Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 829 results for "gilead sciences"

New Gilead Hep C Pill OK'd, Priced 'Low' At $74,760

The Food and Drug Administration on Tuesday approved Gilead Sciences ' ( GILD ) latest hepatitis C pill, which the company priced significantly lower than its previous drugs. The drug, Epclusa, improves upon Gilead's previous drugs Sovaldi and ... Investor's Business Daily, 2 hours ago
[x]  

148 images for gilead sciences

DailyNews724.com, 2 hours ago
American Banking News - Forex, 6 days ago
Self Directed Investor, 6 days ago
Bidness Etc, 3 days ago
Bidness Etc, 2 weeks ago
Bidness Etc, 5 days ago
Jutia Group, 2 weeks ago
Bidness Etc, 3 weeks ago
StatNews.com, 6 minutes ago
Motley Fool, 23 hours ago
Yahoo! Finance UK and Ireland

Gilead's New Hepatitis C Drug Approved by FDA, Priced at $74,760

Gilead Sciences Inc.'s hepatitis C drug was approved by U.S. regulators for all forms of the viral disease, making it the first treatment with such a comprehensive label. The drug, called Epclusa, can be used by patients with any of the six ...
 Bloomberg2 hours ago A drug that can treat all strains of hepatitis C just got approved  Yahoo! Finance UK and Ireland3 hours ago The FDA just approved a drug that treats all kinds of hepatitis C  Business Insider Australia3 hours ago Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug  Xconomy20 hours ago
[x]  
Share Market Updates

Morris Capital Advisors LLC Invests $5,833,000 in Gilead Sciences, Inc. (GILD)

Morris Capital Advisors LLC bought a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD) during the first quarter, Holdings Channel reports. The firm bought 63,495 shares of the biopharmaceutical company's stock, valued at approximately ...
 Ticker Report1 hour ago Ngam Advisors L.P. Increases Position in Gilead Sciences, Inc. (GILD)  SleekMoney1 hour ago Parker Investment Management LLC Purchases Shares of 27,780 Gilead Sciences, Inc. (GILD)  Mideast Time1 hour ago TIAA CREF Investment Management LLC Sells 880,370 Shares of Gilead Sciences, Inc. (GILD)  Mideast Time1 hour ago
[x]  
Nasdaq

Why Is Gilead Sciences (GILD) Stock Gaining Today?

As the global markets continue to deal with the effects of the Brexit, at least one company is bouncing back strong on Tuesday. Gild Sciences GILD gained nearly 3.5% in morning trading today following the approval of its new hepatitis C drug. The ...
 Zacks.com1 hour ago
[x]  

Gilead receives approval for cheaper hepatitis C drug

June 28, 2016 at 13:43 PM EDT Gilead receives approval for cheaper hepatitis C drug Gilead Sciences Inc. received U.S. Food and Drug Administration approval for its Epclusa hepatitis C combination drug and priced the treatment below its older ...
 Marketplace58 minutes ago GILEAD SCIENCES : Gets FDA Approval for Combo Hepatitis C Drug  4 Traders3 hours ago Gilead Gets FDA Approval For Epclusa (Sofosbuvir/Velpatasvir) for All Genotypes Of Chronic Hepatitis C Treatment  Yahoo! Finance1 hour ago Gilead Gets FDA Approval for Combo Hepatitis C Drug  Morningstar.com3 hours ago
[x]  

Gilead wins U.S. nod for drug for all types of hepatitis C

(Reuters) - U.S. health regulators on Tuesday approved a combination drug by Gilead Sciences Inc that is the first available treatment for all six major forms of hepatitis C, advancing the company's leadership in the field and sending its shares up almost 4 ...
 Reuters3 hours ago UPDATE 1-Gilead wins U.S. nod for drug for all types of hepatitis C  Reuters UK2 hours ago
[x]  
HCPLive

GILEAD SCIENCES : U.S. Food and Drug Administration Approves Gilead's Epclusa® (Sofosbuvir/Velpatasvir) for the Treatment of All Genotypes of Chronic Hepatitis C

Epclusa is the First and Only All-Oral, Pan-genotypic Single Tablet Regimen for Chronic Hepatitis C Virus Infection and Gilead's Third Sofosbuvir-Based Regimen Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S. Food and Drug ...
 4 Traders4 hours ago Gilead Rallies Off Epclusa Approval  Benzinga.com3 hours ago U.S. Food and Drug Administration Approves Gilead's Epclusa┬« (Sofosbuvir/Velpatasvir) for the Treatment of All Genotypes of Chronic Hepatitis C  TMC Net51 minutes ago US Food and Drug Administration Approves Gileads Epclusa SofosbuvirVelpatasvir for the Treatment of All Genotypes of Chronic Hepatitis C  Asian Hospital & Healthcare Management2 hours ago
[x]  

FDA Approves Gilead's Epclusa To Treat Genotypes Of Chronic Hepatitis C

Gilead Sciences Inc. (GILD) announced that the U.S. Food and Drug Administration has approved Epclusa (sofosbuvir 400 mg/velpatasvir 100 mg), the first all-oral, pan-genotypic, single tablet regimen for the treatment of adults with genotype 1-6 ...
 RTTNews.com4 hours ago
Motley Fool

When Will Gilead Sciences, Celgene, and CVS Health Hit $100 Again?

Image source: . It's been a rough year to be an investor in Gilead Sciences ( NASDAQ:GILD ) , Celgene ( NASDAQ:CELG ) , or CVS Health ( NYSE:CVS ) . All three of these high-quality healthcare companies started out the year trading for more ...
 Motley Fool23 hours ago

U.S. FDA approves Gilead's hep C drug Epclusa

June 28 (Reuters) - The U.S. Food and Drug Administration approved Gilead Sciences Inc's drug for treating chronic hepatitis C virus infection. The drug, Epclusa, is approved for use in combination with ribavirin. Epclusa is the first drug to ...
 Sharenet4 hours ago U.S. FDA approves Gileads hep C drug Epclusa  Reuters UK3 hours ago FDA approves Gilead's hep C drug Epclusa  Channel NewsAsia3 hours ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - gilead sciences
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less